Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
JP Stock MarketDetailed Quotes
285A Kioxia Holdings Corporation (see below note)
- 1455
- 00.00%
20min DelayMarket Closed Dec 10 09:00 JST
752.96BMarket Cap-4.71P/E (Static)
0High0Low0Volume0Open1455Pre Close0.00Turnover052wk High0.00%Turnover Ratio517.50MShares052wk Low-129.378EPS TTM31.37BFloat Cap0Historical HighLossP/E (Static)21.56MShs Float0Historical Low-309.215EPS LYR0.00%Amplitude--Dividend TTM0.00P/B100Lot Size--Div YieldTTM
Kioxia Holdings Corporation (see below note) Key Stats
Quarterly+Annual
YOY
| (Q1)Jun 30, 2020 | (FY)Mar 31, 2020 | (Q1)Jun 30, 2019 | (FY)Mar 31, 2019 | |
|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||
| Cash from operating activities | 88.30%89.18B | -58.86%239.2B | 47.36B | 581.42B |
| Net profit before non-cash adjustment | 102.15%2.79B | -6,045.64%-238.78B | ---129.62B | --4.02B |
| Total adjustment of non-cash items | -2.71%109.98B | 27.90%490.8B | --113.04B | --383.72B |
| -Depreciation and amortization | 2.80%102.41B | 29.03%411.72B | --99.62B | --319.08B |
| -Reversal of impairment losses recognized in profit and loss | --236M | -4.94%77M | --0 | --81M |
| -Share of associates | 96.57%-6M | 50.81%-212M | ---175M | ---431M |
| -Disposal profit | -356.60%-484M | 19.84%2.6B | ---106M | --2.17B |
| -Other non-cash items | -42.92%7.83B | 21.96%76.62B | --13.71B | --62.82B |
| Changes in working capital | -136.88%-23.58B | -106.62%-12.83B | --63.94B | --193.68B |
| -Change in receivables | -98.43%374M | -172.87%-37.36B | --23.86B | --51.26B |
| -Change in inventory | -184.85%-29.94B | -90.72%9.72B | --35.28B | --104.67B |
| -Change in payables | 20.97%5.52B | -61.47%14.74B | --4.56B | --38.25B |
| -Changes in other current assets | 99.13%460M | 115.57%78M | --231M | ---501M |
| Dividends paid (cash flow from operating activities) | ||||
| Dividends received (cash flow from operating activities) | ||||
| Interest paid (cash flow from operating activities) | 86.25%-7.52B | -133.61%-76.89B | -54.72B | -32.91B |
| Interest received (cash flow from operating activities) | -93.08%74M | -41.82%1.4B | 1.07B | 2.4B |
| Tax refund paid | -492.21%-2.43B | 94.81%-4.59B | -411M | -88.52B |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 |
| Operating cash flow | 1,284.42%79.3B | -65.59%159.12B | ---6.7B | --462.39B |
| Investing cash flow | ||||
| Net PPE purchase and sale | 79.65%-26.41B | 16.12%-351.66B | ---129.76B | ---419.22B |
| Net intangibles purchase and sale | -30.52%-278M | 12.91%-3.86B | ---213M | ---4.43B |
| Net business purchase and sale | ---- | --0 | ---- | ---1.81T |
| Net changes in other investments | -133.58%-231M | 689.81%3.13B | --688M | ---530M |
| Investing cash flow | 79.18%-26.92B | 84.23%-352.39B | ---129.29B | ---2.23T |
| Financing cash flow | ||||
| Net issuance payments of debt | -100.14%-517M | -37.17%406.08B | --374.95B | --646.33B |
| Net common stock issuance | ---- | --0 | ---- | --859.11B |
| Net preferred stock issuance | --0 | -144.07%-234B | ---234B | --531B |
| Increase or decrease of lease financing | -74.74%-4.81B | -37.35%-14.57B | ---2.76B | ---10.61B |
| Net other fund-raising expenses | ---- | -321,500.00%-3.22B | ---- | ---1M |
| Financing cash flow | -103.86%-5.33B | -92.38%154.3B | --138.2B | --2.03T |
| Net cash flow | ||||
| Beginning cash position | -15.55%217.1B | 7,682.77%257.07B | --257.07B | --3.3B |
| Current changes in cash | 2,024.15%47.05B | -115.38%-38.98B | --2.22B | --253.46B |
| Effect of exchange rate changes | 84.54%-94M | -432.11%-993M | ---608M | --299M |
| End cash Position | 2.08%264.05B | -15.55%217.1B | --258.67B | --257.07B |
| Free cash flow | 137.78%51.74B | -675.96%-197.65B | ---136.95B | --34.32B |
| Currency Unit | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |